Roche Holding AG (XTER:RHO) SpecialCharges


XTER:RHO Roche Holding AG XTER:RHO
80 GF Score
Price €368.00
GF Value €295.24
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG SpecialCharges?

Special Charges only applies to banks.

XTER:RHO
80GF Score
Roche Holding AG XTER:RHO
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (XTER:RHO) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of €368.00 is trading 24.6% above its estimated GF Value™ of €295.24. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for XTER:RHO:

  • SpecialCharges:
  • GF Value™: €295.24 vs. price of €368.00 (24.6% above fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the XTER:RHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
80GF Score

Get the complete analysis for XTER:RHO

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€368.00
Price
€295.24
GF Value